Filed: 5/2/2025ACC: 0001104659-25-044118
📋 What this filing means
REGENERON PHARMACEUTICALS, INC. filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $1.23B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$1.23B
Total AUM (reported)
10.57M
Total Shares
Allocation by class
COMMON STOCK$1.23B100.0%
Portfolio Concentration
Top 3$1.23B99.9%
4–10$1.62M0.1%
Top 3 weight
99.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.57M
Sole
Full voting authority
10.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Alnylam Pharmaceuticals, Inc.
SOLEShares4.44M
TypeSH
Market value$1.20B
97.23%
Sole
4.44M
Shared
0.00
None
0.00
Intellia Therapeutics, Inc.
SOLEShares3.70M
TypeSH
Market value$26.33M
2.13%
Sole
3.70M
Shared
0.00
None
0.00
2seventy Bio, Inc.
SOLEShares1.25M
TypeSH
Market value$6.20M
0.50%
Sole
1.25M
Shared
0.00
None
0.00
Adverum Biotechnologies, Inc.
SOLEShares180.91K
TypeSH
Market value$790.6K
0.06%
Sole
180.91K
Shared
0.00
None
0.00
Adicet Bio, Inc.
SOLEShares968.18K
TypeSH
Market value$731.0K
0.06%
Sole
968.18K
Shared
0.00
None
0.00
Bluebird Bio, Inc.
SOLEShares21K
TypeSH
Market value$102.5K
<0.01%
Sole
21K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.SOLE | Common Stock | 4.44M | SH | $1.20B 97.23% | 4.44M | 0.00 | 0.00 |
Intellia Therapeutics, Inc.SOLE | Common Stock | 3.70M | SH | $26.33M 2.13% | 3.70M | 0.00 | 0.00 |
2seventy Bio, Inc.SOLE | Common Stock | 1.25M | SH | $6.20M 0.50% | 1.25M | 0.00 | 0.00 |
Adverum Biotechnologies, Inc.SOLE | Common Stock | 180.91K | SH | $790.6K 0.06% | 180.91K | 0.00 | 0.00 |
Adicet Bio, Inc.SOLE | Common Stock | 968.18K | SH | $731.0K 0.06% | 968.18K | 0.00 | 0.00 |
Bluebird Bio, Inc.SOLE | Common Stock | 21K | SH | $102.5K <0.01% | 21K | 0.00 | 0.00 |